Congenital Immunodeficiency Diseases

Crossroad of Infection, Autoimmunity, and Hyperinflammation. Crossroad of Infection, Autoimmunity, and Hyperinflammation

J. Farmer, K. Csomos, R. Bacchetta, J. E. Walter

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Primary immunodeficiency disorders (PIDs) are genetically predetermined conditions of innate or adaptive immune system dysregulation. Susceptibility toward infection has been a long-standing, often diagnosis-requiring, feature. More recently, autoimmunity as a central pathology in PIDs has been described. Our growing ability to link unique genetic defects with downstream mechanisms that drive hyperinflammation and loss of self-tolerance is extremely powerful. Ultimately, successful management of the PID patient requires not only prevention of infection, but early detection and treatment of autoimmune complications through the use of mechanism-based therapies, which will directly address the immune dysregulation at play.

Original languageEnglish
Title of host publicationTranslational Immunology: Mechanisms and Pharmacologic Approaches
PublisherElsevier Inc.
Pages45-81
Number of pages37
ISBN (Print)9780128015773
DOIs
Publication statusPublished - Dec 19 2015

Fingerprint

Autoimmunity
Self Tolerance
Infection
Immune System
Pathology
Therapeutics

Keywords

  • Autoimmunity
  • Common variable
  • Congenital
  • Hyperinflammation
  • Immunodeficiency
  • Primary

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology and Microbiology(all)

Cite this

Farmer, J., Csomos, K., Bacchetta, R., & Walter, J. E. (2015). Congenital Immunodeficiency Diseases: Crossroad of Infection, Autoimmunity, and Hyperinflammation. Crossroad of Infection, Autoimmunity, and Hyperinflammation. In Translational Immunology: Mechanisms and Pharmacologic Approaches (pp. 45-81). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-801577-3.00002-2

Congenital Immunodeficiency Diseases : Crossroad of Infection, Autoimmunity, and Hyperinflammation. Crossroad of Infection, Autoimmunity, and Hyperinflammation. / Farmer, J.; Csomos, K.; Bacchetta, R.; Walter, J. E.

Translational Immunology: Mechanisms and Pharmacologic Approaches. Elsevier Inc., 2015. p. 45-81.

Research output: Chapter in Book/Report/Conference proceedingChapter

Farmer, J, Csomos, K, Bacchetta, R & Walter, JE 2015, Congenital Immunodeficiency Diseases: Crossroad of Infection, Autoimmunity, and Hyperinflammation. Crossroad of Infection, Autoimmunity, and Hyperinflammation. in Translational Immunology: Mechanisms and Pharmacologic Approaches. Elsevier Inc., pp. 45-81. https://doi.org/10.1016/B978-0-12-801577-3.00002-2
Farmer J, Csomos K, Bacchetta R, Walter JE. Congenital Immunodeficiency Diseases: Crossroad of Infection, Autoimmunity, and Hyperinflammation. Crossroad of Infection, Autoimmunity, and Hyperinflammation. In Translational Immunology: Mechanisms and Pharmacologic Approaches. Elsevier Inc. 2015. p. 45-81 https://doi.org/10.1016/B978-0-12-801577-3.00002-2
Farmer, J. ; Csomos, K. ; Bacchetta, R. ; Walter, J. E. / Congenital Immunodeficiency Diseases : Crossroad of Infection, Autoimmunity, and Hyperinflammation. Crossroad of Infection, Autoimmunity, and Hyperinflammation. Translational Immunology: Mechanisms and Pharmacologic Approaches. Elsevier Inc., 2015. pp. 45-81
@inbook{275a86f75f794b60acf191c09e2d73d8,
title = "Congenital Immunodeficiency Diseases: Crossroad of Infection, Autoimmunity, and Hyperinflammation. Crossroad of Infection, Autoimmunity, and Hyperinflammation",
abstract = "Primary immunodeficiency disorders (PIDs) are genetically predetermined conditions of innate or adaptive immune system dysregulation. Susceptibility toward infection has been a long-standing, often diagnosis-requiring, feature. More recently, autoimmunity as a central pathology in PIDs has been described. Our growing ability to link unique genetic defects with downstream mechanisms that drive hyperinflammation and loss of self-tolerance is extremely powerful. Ultimately, successful management of the PID patient requires not only prevention of infection, but early detection and treatment of autoimmune complications through the use of mechanism-based therapies, which will directly address the immune dysregulation at play.",
keywords = "Autoimmunity, Common variable, Congenital, Hyperinflammation, Immunodeficiency, Primary",
author = "J. Farmer and K. Csomos and R. Bacchetta and Walter, {J. E.}",
year = "2015",
month = "12",
day = "19",
doi = "10.1016/B978-0-12-801577-3.00002-2",
language = "English",
isbn = "9780128015773",
pages = "45--81",
booktitle = "Translational Immunology: Mechanisms and Pharmacologic Approaches",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Congenital Immunodeficiency Diseases

T2 - Crossroad of Infection, Autoimmunity, and Hyperinflammation. Crossroad of Infection, Autoimmunity, and Hyperinflammation

AU - Farmer, J.

AU - Csomos, K.

AU - Bacchetta, R.

AU - Walter, J. E.

PY - 2015/12/19

Y1 - 2015/12/19

N2 - Primary immunodeficiency disorders (PIDs) are genetically predetermined conditions of innate or adaptive immune system dysregulation. Susceptibility toward infection has been a long-standing, often diagnosis-requiring, feature. More recently, autoimmunity as a central pathology in PIDs has been described. Our growing ability to link unique genetic defects with downstream mechanisms that drive hyperinflammation and loss of self-tolerance is extremely powerful. Ultimately, successful management of the PID patient requires not only prevention of infection, but early detection and treatment of autoimmune complications through the use of mechanism-based therapies, which will directly address the immune dysregulation at play.

AB - Primary immunodeficiency disorders (PIDs) are genetically predetermined conditions of innate or adaptive immune system dysregulation. Susceptibility toward infection has been a long-standing, often diagnosis-requiring, feature. More recently, autoimmunity as a central pathology in PIDs has been described. Our growing ability to link unique genetic defects with downstream mechanisms that drive hyperinflammation and loss of self-tolerance is extremely powerful. Ultimately, successful management of the PID patient requires not only prevention of infection, but early detection and treatment of autoimmune complications through the use of mechanism-based therapies, which will directly address the immune dysregulation at play.

KW - Autoimmunity

KW - Common variable

KW - Congenital

KW - Hyperinflammation

KW - Immunodeficiency

KW - Primary

UR - http://www.scopus.com/inward/record.url?scp=84960806122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960806122&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-801577-3.00002-2

DO - 10.1016/B978-0-12-801577-3.00002-2

M3 - Chapter

SN - 9780128015773

SP - 45

EP - 81

BT - Translational Immunology: Mechanisms and Pharmacologic Approaches

PB - Elsevier Inc.

ER -